D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2076
AppFolio
APPF
$10.1B
| $496K | ﹤0.01% |
6,250
-5,013
| -45% | -$398K |
|
|
RRD
2077
DELISTED
RR Donnelley & Sons Co.
RRD
| $493K | ﹤0.01% |
104,500
-153,497
| -59% | -$724K |
|
2078
American Vanguard Corp
AVD
$154M
| $489K | ﹤0.01% |
28,376
-8,695
| -23% | -$150K |
|
2079
Ryman Hospitality Properties
RHP
$6.39B
| $484K | ﹤0.01% |
5,883
-65,619
| -92% | -$5.4M |
|
|
CLDR
2080
DELISTED
Cloudera, Inc.
CLDR
| $482K | ﹤0.01% |
+44,021
| New | +$482K |
|
2081
Tucows
TCX
$202M
| $481K | ﹤0.01% |
+5,925
| New | +$481K |
|
|
SUP
2082
DELISTED
Superior Industries International
SUP
| $480K | ﹤0.01% |
100,826
-89,772
| -47% | -$427K |
|
|
USCR
2083
DELISTED
U S Concrete, Inc.
USCR
| $478K | ﹤0.01% |
11,542
-10,579
| -48% | -$438K |
|
2084
BancFirst
BANF
$4.48B
| $476K | ﹤0.01% |
9,118
+4,633
| +103% | +$242K |
|
2085
Omnicom Group
OMC
$14.9B
| $474K | ﹤0.01% |
+6,488
| New | +$474K |
|
2086
Church & Dwight Co
CHD
$22.8B
| $471K | ﹤0.01% |
6,606
-8,459
| -56% | -$603K |
|
2087
Invesco QQQ Trust
QQQ
$372B
| $471K | ﹤0.01% |
+2,624
| New | +$471K |
|
|
RVNC
2088
DELISTED
Revance Therapeutics, Inc.
RVNC
| $469K | ﹤0.01% |
29,729
-70,761
| -70% | -$1.12M |
|
2089
Globe Life
GL
$11.4B
| $468K | ﹤0.01% |
5,714
-596
| -9% | -$48.8K |
|
2090
Nelnet
NNI
$4.48B
| $468K | ﹤0.01% |
8,503
-174
| -2% | -$9.58K |
|
|
CMD
2091
DELISTED
Cantel Medical Corporation
CMD
| $468K | ﹤0.01% |
7,001
-41,586
| -86% | -$2.78M |
|
|
SFE
2092
DELISTED
Safeguard Scientifics, Inc.
SFE
| $465K | ﹤0.01% |
42,899
+1,250
| +3% | +$13.5K |
|
2093
Guess, Inc.
GES
$869M
| $463K | ﹤0.01% |
23,617
-240,750
| -91% | -$4.72M |
|
2094
Stifel
SF
$11.7B
| $461K | ﹤0.01% |
13,118
-8,893
| -40% | -$313K |
|
|
PTLA
2095
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $459K | ﹤0.01% |
+13,235
| New | +$459K |
|
2096
AAR Corp
AIR
$2.71B
| $458K | ﹤0.01% |
14,092
-2,990
| -18% | -$97.2K |
|
2097
Adient
ADNT
$1.98B
| $456K | ﹤0.01% |
35,161
-9,085
| -21% | -$118K |
|
|
HMTV
2098
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $455K | ﹤0.01% |
32,267
-3,385
| -9% | -$47.7K |
|
|
SECO
2099
DELISTED
Secoo Holding Limited ADR
SECO
| $448K | ﹤0.01% |
+5,112
| New | +$448K |
|
2100
Horizon Bancorp
HBNC
$839M
| $444K | ﹤0.01% |
27,581
+2,393
| +10% | +$38.5K |
|